Literature DB >> 30636919

Utility of CD64 on Neutrophils in Orthopedic Infection.

Akihiro Fujita1, Shinji Tanishima1, Yoshihiro Kato1, Ryota Teshima1, Hideki Nagashima1.   

Abstract

BACKGROUND: Musculoskeletal infections are often seen in the daily practice of orthopedics. Several markers [white blood cell (WBC), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT)] have been used for diagnosing these infections. However, these markers may be elevated due to surgery or trauma, and may not be infection-related. These markers also show drug-dependent dynamics during infection that differ from its usual dynamics. Such situations make diagnosis of infections difficult, and Cluster of Differentiation 64 (CD64) has been brought to attention. This study aimed to clarify the utility of CD64 on neutrophils by comparing it with conventional infection markers (CRP, PCT) in musculoskeletal infection.
METHODS: Forty-four patients who were suspected of having musculoskeletal infection between May 2010 and November 2013 in our hospital were enrolled in this study. Patients were divided into subgroups according to their culture results, antibiotics administration, measurement timing, and if they were immunocompromised. The measurements of the infection markers were compared between each group. In addition, the positive rates of each infection marker were compared between groups.
RESULTS: There was no difference in the infection marker measurements between several groups. There was no statistically significant difference between groups for the positive rates of CD64, CRP, and PCT.
CONCLUSION: We evaluated the utility of CD64 on neutrophils in musculoskeletal infection. CD64 showed the utility that was equivalent to conventional infection markers in diagnoses of various musculoskeletal infections.

Entities:  

Keywords:  C-reactive protein; Cluster of Differentiation 64; musculoskeletal infections; procalcitonin

Year:  2018        PMID: 30636919      PMCID: PMC6308103     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  20 in total

Review 1.  Use of plasma procalcitonin levels as an adjunct to clinical microbiology.

Authors:  David N Gilbert
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

2.  Neutrophil CD64 as a marker of infection in patients treated with tocilizumab.

Authors:  Toshihiro Matsui; Akiko Komiya; Kota Shimada; Hisanori Nakayama; Shigeto Tohma
Journal:  Mod Rheumatol       Date:  2009       Impact factor: 3.023

3.  Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients.

Authors:  Bruce H Davis; Stephen H Olsen; Ejaz Ahmad; Nancy C Bigelow
Journal:  Arch Pathol Lab Med       Date:  2006-05       Impact factor: 5.534

4.  Neutrophil CD64 expression: distinguishing acute inflammatory autoimmune disease from systemic infections.

Authors:  E Allen; A C Bakke; M Z Purtzer; A Deodhar
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 5.  Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis.

Authors:  Joan Cid; Reyes Aguinaco; Rafael Sánchez; Graciano García-Pardo; Andreu Llorente
Journal:  J Infect       Date:  2010-03-03       Impact factor: 6.072

6.  Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.

Authors:  R Repp; T Valerius; A Sendler; M Gramatzki; H Iro; J R Kalden; E Platzer
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

7.  CD64 on neutrophils is a sensitive and specific marker for detection of infection in patients with rheumatoid arthritis.

Authors:  Toshihiro Matsui; Kayoko Ohsumi; Naoko Ozawa; Kota Shimada; Shuji Sumitomo; Kenichi Shimane; Misato Kawakami; Hisanori Nakayama; Shoji Sugii; Yoshinori Ozawa; Shigeto Tohma
Journal:  J Rheumatol       Date:  2006-10-15       Impact factor: 4.666

8.  Neutrophil CD64 as a marker for postoperative infection: a pilot study.

Authors:  A Daryapeyma; G Pedersen; E Laxdal; M Corbascio; H B Johannessen; S Aune; T Jonung
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-04-08       Impact factor: 7.069

9.  Hematological indices, inflammatory markers and neutrophil CD64 expression: comparative trends during experimental human endotoxemia.

Authors:  Wim van der Meer; Peter Pickkers; Colin S Scott; Johannes G van der Hoeven; Jacqueline Klein Gunnewiek
Journal:  J Endotoxin Res       Date:  2007

10.  Neutrophil CD64 expression in the diagnosis of local musculoskeletal infection and the impact of antibiotics.

Authors:  S Tanaka; J Nishino; T Matsui; A Komiya; K Nishimura; S Tohma
Journal:  J Bone Joint Surg Br       Date:  2009-09
View more
  1 in total

1.  Analysis of Risk Factors and Association of Cluster of Differentiation (CD) Markers With Conventional Markers in Delayed Fracture Related Infection for Closed Fracture.

Authors:  Archana Raikwar; Ajai Singh; Vikas Verma; Abbas Ali Mehdi; Narendra Singh Kushwaha; Rashmi Kushwaha
Journal:  Cureus       Date:  2021-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.